| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| CA | 314 | 48.4% | -3.84 | 22 | 50.0% |
| MB | 314 | 48.4% | -3.84 | 22 | 50.0% |
| CentralBrain-unspecified | 21 | 3.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KC | % In | CV |
|---|---|---|---|---|---|
| VA6_adPN | 1 | ACh | 21.5 | 13.4% | 0.0 |
| DM1_lPN | 1 | ACh | 15 | 9.4% | 0.0 |
| DM2_lPN | 1 | ACh | 13.5 | 8.4% | 0.0 |
| VA2_adPN | 1 | ACh | 12.5 | 7.8% | 0.0 |
| VL2a_adPN | 1 | ACh | 11.5 | 7.2% | 0.0 |
| VC1_lPN | 1 | ACh | 11.5 | 7.2% | 0.0 |
| VA7l_adPN | 1 | ACh | 11 | 6.9% | 0.0 |
| APL | 2 | GABA | 11 | 6.9% | 0.0 |
| VP1d+VP4_l2PN1 | 1 | ACh | 10 | 6.2% | 0.0 |
| LHPV12a1 | 2 | GABA | 7.5 | 4.7% | 0.0 |
| MB-C1 | 3 | GABA | 6 | 3.8% | 0.7 |
| VA7m_lPN | 1 | ACh | 5.5 | 3.4% | 0.0 |
| KCab-s | 9 | ACh | 5.5 | 3.4% | 0.3 |
| DC2_adPN | 1 | ACh | 5 | 3.1% | 0.0 |
| DM5_lPN | 1 | ACh | 3.5 | 2.2% | 0.0 |
| KCg-m | 6 | ACh | 3 | 1.9% | 0.0 |
| KCab-m | 3 | ACh | 2 | 1.2% | 0.0 |
| KCa'b'-m | 2 | ACh | 1 | 0.6% | 0.0 |
| KCa'b'-ap2 | 1 | ACh | 0.5 | 0.3% | 0.0 |
| VL2p_adPN | 1 | ACh | 0.5 | 0.3% | 0.0 |
| PPL202 | 1 | DA | 0.5 | 0.3% | 0.0 |
| KCab-c | 1 | ACh | 0.5 | 0.3% | 0.0 |
| FB2G_a | 1 | Glu | 0.5 | 0.3% | 0.0 |
| LHCENT1 | 1 | GABA | 0.5 | 0.3% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.5 | 0.3% | 0.0 |
| downstream partner | # | NT | conns KC | % Out | CV |
|---|---|---|---|---|---|
| APL | 2 | GABA | 8 | 38.1% | 0.0 |
| KCg-m | 5 | ACh | 3 | 14.3% | 0.3 |
| MBON22 | 1 | ACh | 1.5 | 7.1% | 0.0 |
| KCab-s | 3 | ACh | 1.5 | 7.1% | 0.0 |
| LHPV12a1 | 1 | GABA | 1 | 4.8% | 0.0 |
| KCa'b'-ap2 | 2 | ACh | 1 | 4.8% | 0.0 |
| KCa'b'-m | 2 | ACh | 1 | 4.8% | 0.0 |
| KCab-c | 1 | ACh | 0.5 | 2.4% | 0.0 |
| VM5d_adPN | 1 | ACh | 0.5 | 2.4% | 0.0 |
| MB-C1 | 1 | GABA | 0.5 | 2.4% | 0.0 |
| VA4_lPN | 1 | ACh | 0.5 | 2.4% | 0.0 |
| LHMB1 | 1 | Glu | 0.5 | 2.4% | 0.0 |
| KCab-m | 1 | ACh | 0.5 | 2.4% | 0.0 |
| LHCENT1 | 1 | GABA | 0.5 | 2.4% | 0.0 |
| LHCENT4 | 1 | Glu | 0.5 | 2.4% | 0.0 |
